Muscle News and Research

RSS

Researchers use new technique to create 3D-printed medical implants

Researchers have flipped traditional 3D printing to create some of the most intricate biomedical structures yet, advancing the development of new technologies for regrowing bones and tissue.

26 May 2021

Men with low testosterone levels are more susceptible to severe COVID-19

Throughout the pandemic, doctors have seen evidence that men with COVID-19 fare worse, on average, than women with the infection.

25 May 2021

Low-calorie ketogenic diet can increase testosterone levels in overweight men

New research reveals that a low-calorie ketogenic diet can help testosterone levels in overweight men, reducing overall levels of obesity.

24 May 2021

Tips for older adults to regain their game after being cooped up for more than a year

Alice Herb, 88, an intrepid New Yorker, is used to walking miles around Manhattan. But after this year of being shut inside, trying to avoid covid-19, she's noticed a big difference in how she feels.

24 May 2021

New level of control over stem cells will help accelerate research, lead to therapeutic applications

Researchers from Tokyo Metropolitan University have been quantifying how different batches of mesenchymal stem cells respond to the mechanical stiffness of their environments.

22 May 2021

Oxytocin-vasopressin circuit has distinct dynamics throughout embryonic development

The work, carried out by Pilar Madrigal and Sandra Jurado, from the UMH-CSIC Neurosciences Institute in Alicante, a joint center of the Spanish National Research Council and Miguel Hernández University, has been published in Communications Biology, a Nature group´s journal.

22 May 2021

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

21 May 2021

New device detects signs of sudden cardiac death

Scientists of Tomsk Polytechnic University have developed a nanosensor-based hardware and software complex for measurement of cardiac micropotential energies without filtering and averaging-out cardiac cycles in real time.

21 May 2021

As pandemic eases, many seniors have lost strength, may need rehabilitative services

Ronald Lindquist, 87, has been active all his life. So, he wasn't prepared for what happened when he stopped going out during the coronavirus pandemic and spent most of his time, inactive, at home.

21 May 2021

Facets of SARS-CoV-2 infection and animal models

A new study in the journal Frontiers in Cell and Developmental Biology discusses the ribonucleic acid (RNA) genome of the virus, and the mechanisms by which it establishes infection within the host cell. The researchers also summarize the development of animal models of COVID-19, which will both help understand the clinical features of the illness, and indicate new approaches for the treatment of the infection.

21 May 2021

Scientists discover key component to repair the molecular motor of human heart

A team of scientists from Loyola University Chicago's Stritch School of Medicine have discovered a critical component for renewing the heart's molecular motor, which breaks down in heart failure.

20 May 2021

Seed money: Black entrepreneurs hope pandemic gardening boom will grow healthier eating

Ietef Vita had planned to spend most of 2020 on the road, promoting "Biomimicz," the album the rapper had released on his #plantbasedrecords label in January.

20 May 2021

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.

20 May 2021

Protein intake is more important than protein source to gain muscle strength and mass

Protein intake is more important than protein source if the goal is to gain muscle strength and mass.

19 May 2021

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Writing in the May 14, 2021 issue of The American Journal of Psychiatry, a multi-institution team of scientists led by researchers at University of California San Diego School of Medicine report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients.

18 May 2021

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

A team of McMaster University researchers who studied heart patients found that stair-climbing routines, whether vigorous or moderate, provide significant cardiovascular and muscular benefits.

18 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Pirfenidone significantly reduces a marker of heart muscle scarring

Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

Most COVID-19 patients have neurological symptoms

In a new study, published in the journal JAMA Network, University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19 found that neurological manifestations were prevalent among patients hospitalized with COVID-19. The patients were also at a higher risk of in-hospital mortality.

17 May 2021

Muscle News and Research

Researchers use new technique to create 3D-printed medical implants

Men with low testosterone levels are more susceptible to severe COVID-19

Low-calorie ketogenic diet can increase testosterone levels in overweight men

Tips for older adults to regain their game after being cooped up for more than a year

New level of control over stem cells will help accelerate research, lead to therapeutic applications

Oxytocin-vasopressin circuit has distinct dynamics throughout embryonic development

FDA approves Rybrevant for treating subset of non-small cell lung cancer

New device detects signs of sudden cardiac death

As pandemic eases, many seniors have lost strength, may need rehabilitative services

Facets of SARS-CoV-2 infection and animal models

Scientists discover key component to repair the molecular motor of human heart

Seed money: Black entrepreneurs hope pandemic gardening boom will grow healthier eating

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

Protein intake is more important than protein source to gain muscle strength and mass

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Pirfenidone significantly reduces a marker of heart muscle scarring

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

Most COVID-19 patients have neurological symptoms

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News